publication date: Feb. 27, 2015

Former MD Anderson Faculty Chairs: “We are Disheartened and Dismayed At the Precipitous Decline in Faculty Morale”

 

A group of eight past chairs of the MD Anderson Cancer Center Faculty Senate have weighed into the controversy over leadership and morale at the Houston-based hospital.

“As former chairs, we are disheartened and dismayed at the precipitous decline in faculty morale that has occurred at MDACC under the current executive leadership,” the past chairs wrote in an email distributed to the faculty on Feb. 26. “We are further troubled by the continuing loss of outstanding long-term senior faculty from MDACC, an exodus that many have attributed to current administrative policies.”

The group’s letter suggests that discussion of morale at the cancer center is becoming more open at a time when its current president, Ronald DePinho, is on notice to improve his relationship with the faculty.

With this latest salvo from the eight past chairs, peace between DePinho and the faculty is slipping further from the embattled president’s grasp. No commander wants open conflict with his troops. Yet, open conflict appears to be exactly what DePinho has on his hands.

There has been a call for the UT System to march in, a petition from DePinho loyalists, and a letter from luminaries disgusted by what they describe as demands for a “loyalty oath.” Worse, the people DePinho reports to made their wishes clear late last year: solve the problem (The Cancer Letter, Nov. 7, 2014).

And that was before former Adm. William McRaven became the UT System … Continue reading 41-08 Former MD Anderson Faculty Chairs: “We are Disheartened and Dismayed At the Precipitous Decline in Faculty Morale”

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.